316 related articles for article (PubMed ID: 31306132)
1. Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?
Mendes T; Cardoso S; Guerreiro M; Maroco J; Silva D; Alves L; Schmand B; Gerardo B; Lima M; Santana I; de Mendonça A
J Alzheimers Dis; 2019; 70(4):1103-1111. PubMed ID: 31306132
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment.
Alves L; Cardoso S; Silva D; Mendes T; Marôco J; Nogueira J; Lima M; Tábuas-Pereira M; Baldeiras I; Santana I; de Mendonça A; Guerreiro M
J Neuropsychol; 2021 Apr; 15 Suppl 1():41-52. PubMed ID: 32588984
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI.
Sundermann EE; Maki P; Biegon A; Lipton RB; Mielke MM; Machulda M; Bondi MW;
Neurology; 2019 Nov; 93(20):e1881-e1889. PubMed ID: 31597708
[TBL] [Abstract][Full Text] [Related]
5. Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults.
Sundermann EE; Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Rubin LH; Bondi MW;
J Alzheimers Dis; 2018; 61(3):1163-1178. PubMed ID: 29332038
[TBL] [Abstract][Full Text] [Related]
6. Alteration of regional homogeneity and white matter hyperintensities in amnestic mild cognitive impairment subtypes are related to cognition and CSF biomarkers.
Luo X; Jiaerken Y; Huang P; Xu XJ; Qiu T; Jia Y; Shen Z; Guan X; Zhou J; Zhang M;
Brain Imaging Behav; 2018 Feb; 12(1):188-200. PubMed ID: 28236166
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
8. Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study.
Liu Y; Pan N; Ma Y; Zhang S; Guo W; Li H; Zhou J; Liu G; Gao M
Am J Med Sci; 2013 May; 345(5):355-60. PubMed ID: 23044653
[TBL] [Abstract][Full Text] [Related]
9. CSF Aβ
Rizzi L; Maria Portal M; Batista CEA; Missiaggia L; Roriz-Cruz M
Brain Res; 2018 Jan; 1678():27-31. PubMed ID: 29017912
[TBL] [Abstract][Full Text] [Related]
10. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D
Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545
[TBL] [Abstract][Full Text] [Related]
11. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
12. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
Ryu SY; Lee SB; Kim TW; Lee TJ
Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
[TBL] [Abstract][Full Text] [Related]
13. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
Marizzoni M; Ferrari C; Macis A; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Pizzini F; Rossini PM; Salvatore M; Schönknecht P; Soricelli A; Del Percio C; Hensch T; Hegerl U; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
J Alzheimers Dis; 2019; 69(1):49-58. PubMed ID: 30958351
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.
Seo EH; Choo IL;
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1088-95. PubMed ID: 26613793
[TBL] [Abstract][Full Text] [Related]
15. Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
Schneider LS; Kennedy RE; Cutter GR;
Alzheimers Dement; 2010 Sep; 6(5):367-77. PubMed ID: 20813339
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment.
Kang SH; Cheon BK; Kim JS; Jang H; Kim HJ; Park KW; Noh Y; Lee JS; Ye BS; Na DL; Lee H; Seo SW
J Alzheimers Dis; 2021; 80(1):143-157. PubMed ID: 33523003
[TBL] [Abstract][Full Text] [Related]
17. Biomarker positive and negative subjects in the ADNI cohort: clinical characterization.
Kennedy RE; Schneider LS; Cutter GR;
Curr Alzheimer Res; 2012 Dec; 9(10):1135-41. PubMed ID: 22963265
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
19. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
20. In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion.
Hessen E; Kirsebom BE; Eriksson CM; Eliassen CF; Nakling AE; Bråthen G; Waterloo KK; Aarsland D; Fladby T
J Alzheimers Dis; 2019; 67(2):715-723. PubMed ID: 30614807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
